XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional paid-in capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Ordinary shares, beginning balance (in shares) at Dec. 31, 2022   94,843,391      
Beginning balance at Dec. 31, 2022 $ 336,169 $ 265 $ 939,261 $ (1,497) $ (601,860)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 7,190   7,190    
Vesting of ordinary shares (in shares)   332,292      
Vesting of ordinary shares 0 $ 1 (1)    
Shares withheld to pay employee withholding tax on share-based compensation (in shares)   (72,436)      
Shares withheld to pay employee withholding tax on share-based compensation (282)   (282)    
Foreign currency translation adjustments 898     898  
Unrealized gain on available for sale securities, net of tax 0        
Net loss (50,714)       (50,714)
Ordinary shares, ending balance (in shares) at Mar. 31, 2023   95,103,247      
Ending balance at Mar. 31, 2023 $ 293,261 $ 266 946,168 (599) (652,574)
Ordinary shares, beginning balance (in shares) at Dec. 31, 2023 98,774,827 98,774,827      
Beginning balance at Dec. 31, 2023 $ 236,244 $ 273 987,423 1,493 (752,945)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of ordinary shares under ATM program, net of issuance costs (in shares)   1,250,000      
Issuance of ordinary shares under ATM program, net of issuance costs $ 9,655 $ 3 9,652    
Stock option exercises (in shares) 176,460 176,460      
Stock option exercises $ 955   955    
Share-based compensation expense 8,154   8,154    
Vesting of ordinary shares (in shares)   480,926      
Vesting of ordinary shares 0 $ 1 (1)    
Shares withheld to pay employee withholding tax on share-based compensation (in shares)   (200,220)      
Shares withheld to pay employee withholding tax on share-based compensation (1,929)   (1,929)    
Foreign currency translation adjustments (25)     (25)  
Unrealized gain on available for sale securities, net of tax 155     155  
Net loss $ (38,046)       (38,046)
Ordinary shares, ending balance (in shares) at Mar. 31, 2024 100,481,993 100,481,993      
Ending balance at Mar. 31, 2024 $ 215,163 $ 277 $ 1,004,254 $ 1,623 $ (790,991)